Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer (PROVE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by WiSP Wissenschaftlicher Service Pharma GmbH.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
ClinAssess GmbH
Information provided by (Responsible Party):
WiSP Wissenschaftlicher Service Pharma GmbH
ClinicalTrials.gov Identifier:
NCT01388621
First received: May 17, 2011
Last updated: August 19, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)